Drugs / HLA-haploidentical related hematopoietic cells transplant
HLA-haploidentical related hematopoietic cells transplant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02988466 | Jan 2017 → May 2023 | hematopoietic and lymphoid cell neoplasm | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HLA-haploidentical related hematopoietic cells transplant | “HLA-haploidentical related hematopoietic cells transplant” NCT02988466 ↗1“HLA-haploidentical related hematopoietic cells transplant” NCT02988466 ↗ |
| Modality | Cell therapy | “Non-T-cell depleted donor bone marrow stem cell infusion Day 0” NCT02988466 ↗ |